Workflow
*ST长药(300391.SZ):因涉嫌定期报告等财务数据虚假记载 证监会对公司立案
Ge Long Hui A P P·2025-11-07 10:43

Core Viewpoint - *ST Changyao (300391.SZ) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into suspected false reporting of financial data, which may lead to significant penalties and potential delisting if found guilty [1] Summary by Relevant Sections - Investigation Details - The company is under investigation for allegedly falsifying financial data in periodic reports, as indicated by the CSRC's notice (Case No. 0042025020) [1] - Legal Framework - The investigation is based on violations of the Securities Law of the People's Republic of China and the Administrative Penalty Law, among other regulations [1] - Potential Consequences - If the CSRC confirms the violations, the company may face mandatory delisting under the Shenzhen Stock Exchange's rules for significant legal violations [1]